Changes in plasma taurine concentration during a period of heroin detoxification

Toxicological and Environmental Chemistry

Volumn 92, Issue 8, 2010, Pages 1505-1512

  Ghandforoush Sattari, Mohammadreza ^a,b,c   Mashayekhi, Simin O ^a,b   Nemati, Mahboob ^a   Seydi, Ali ^d   Azadi, Hamid ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Addiction; Biomarker; Heroine; Opiates; Stress; Taurine

Indexed keywords

ADDICTION; BLOOD SAMPLES; FLUORESCENCE DETECTION; GLASS TUBES; HEALTHY CONTROLS; HEROIN ADDICTS; HEROINE; HPLC METHOD; OPIATES; STRESS STATE; TAURINE;

AMINO ACIDS; CENTRIFUGATION; CONCENTRATION (PROCESS); DETOXIFICATION; ORGANIC ACIDS;

PLASMAS;

AMINO ACID; BIOCHEMICAL COMPOSITION; BIOMARKER; DETOXIFICATION; DRUG; DRUG USER; LIQUID CHROMATOGRAPHY; PLASMA; PUBLIC HEALTH; SERUM;

EID: 77955902034     PISSN: 02772248     EISSN: 10290486     Source Type: Journal    
DOI: 10.1080/02772240903410003     Document Type: Article

References (43)

1. Alford, C., H. Cox, and R. Wescott. 2001. The effects of red bull energy drink on human performance and mood. Amino Acids 21: 139-50.
2. Banks, M.F., and M.H. Stipanuk. 1994. The utilization of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine. Journal of Nutrition 124: 378-87.
3. Bhatnagar, S.K., J.D. Welty, and A.R. Al Yusuf. 1990. Significance of blood taurine levels in patients with first time acute ischaemic cardiac pain. International Journal of Cardiology 27: 361-6.
4. Birdsall, T.C. 1998. Therapeutic applications of taurine. Alternative Medicine Review 3: 128-36.
5. Butterworth, R.F. 1996. Taurine in hepatic encephalopathy. Advances in Experimental Medicine and Biology 403: 601-6.
6. Carvalho, F., C.J. Waterfield, M. Ferreira, M. de Lourdes Bastos, and J.A. Timbrell. 1994. Effect of repeated exposure to salbutamol on urinary and liver taurine levels in rats. Human and Experimental Toxicology 13: 291.
7. Chiarla, C., I. Giovannini, J.H. Siegel, G. Boldrini, and M. Castagneto. 2000. The relationship between plasma taurine and other amino acid levels in human sepsis. Journal of Nutrition 130: 2222-7.
8. Cousins, M.S., D.C. Roberts, and H. de Wit. 2002. GABA(B) receptor agonists for the treatment of drug addiction: A review of recent findings. Drug Alcohol Dependence 65: 209-20.
9. De Leon-Jones, F.A., J.M. Davis, E.E. Inwang, and H. Dekirmenjian. 1983. Excretion of catecholamine metabolites during methadone maintenance and withdrawal. Archives of General Psychiatry 40: 841-7.
10. Desai, T.K., J. Maliakkal, J.L. Kinzie, M.N. Ehrinpreis, G.D. Luk, and J. Cejka. 1992. Taurine deficiency after intensive chemotherapy and/or radiation. American Journal of Clinical Nutrition 55: 708-11.
11. Di Ciano, P., and B.J. Everitt. 2003. The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacol 28: 510-8.
12. Fekkes, D., L. Timmerman, G.J. van Gelderen, and L. Pepplinkhuizen. 1996. Norharman next term in multiple previous term drug-addicts next term and healthy controls. European Neuropsychopharmacol 6: S4.
13. Friedman, A.L., P.W. Albright, N. Gusowski, M. Padilla, and R.W. Chesney. 1983. Renal adaptation to alteration in dietary amino acid intake. American Journal of Physiology 245: F159-66.
14. Ghandforoush-Sattari, M., and S. Mashayekhi. 2008. Evaluation of taurine as a biomarker of liver damage in paracetamol poisoning. European Journal of Pharmacology 581: 171-6.
15. Ghandforoush-Sattari, M., S. Mashayekhi, M. Nemati, and P.A. Routledge. 2009. A rapid determination of taurine in human plasma by LC. Chromatographia 69: 1427-30.
16. Guardia, J., M. Casas, G. Prat, J. Trujols, L. Segura, and M. Sanchez-Turet. 2002. The apomorphine test: A biological marker for heroin dependence disorder? Addiction Biology 7: 421-6.
17. Guerra-Romero, L., J.H. Tureen, M.A. Fournier, V. Makrides, and M.G. Tauber. 1993. Amino acids in cerebrospinal and brain interstitial fluid in experimental pneumococcal meningitis. Pediatric Research 33: 510-3.
18. Gupta, R.C., T. Win, and S. Bittner. 2005. Taurine analogues; a new class of therapeutics: Retrospect and prospects. Current Medicinal Chemistry 12: 2021-39.
19. Harry, F., A. Hale, D. Buss, A. Hutchings, and P. Routledge. 1999. Serum taurine levels in healthy subjects and in paracetamol poisoned patients. Human and Experimental Toxicology 18: 495-539.
20. Huxtable, R.J. 1992. Physiological actions of taurine. Physiological Reviews 72: 101-63.
21. Kendler, B.S. 1989. Taurine: An overview of its role in preventive medicine. Preventive Medicine 18: 79-100.
22. Kintz, P., C. Jamey, V. Cirimele, R. Brenneisen, and B. Ludes. 1998. Evaluation of acetylcodeine as a specific marker of illicit heroin in human hair. Journal of Analytical Toxicology 22: 425-9.
23. Kirk, K., and J. Kirk. 1993. Volume-regulatory taurine release from a human lung cancer cell line. Evidence for amino acid transport via a volume-activated chloride channel. Federation of the Society of Biochemistry and Molecular Biology Letter 336: 153-8.
24. Kish, S.J., K.S. Kalasinsky, Y. Furukawa, M. Guttman, L. Ang, L. Li, V. Adams, et al. 1999. Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin. Molecular Psychiatry 4: 26-32.
25. Kovacic, P. 2005. Role of oxidative metabolites of cocaine in toxicity and addiction: Oxidative stress and electron transfer. Medical Hypotheses 64: 350-6.
26. Law, R.O. 1998. The role of taurine in the regulation of brain cell volume in chronically hyponatraemic rats. Neurochemistry International 33: 467-72.
27. Lee, P., and D. Brenton. 2003. Inborn errors of amino acid and organic acid metabolism. In Oxford textbook of medicine, ed. D. Warrell, T. Cox and J. Firth, 9-31. Oxford: Oxford University Press.
28. Lowinson, J.H., P. Ruiz, R.B. Millman, and J.G. Langrod. 2005. Substance abuse: A comprehensive textbook. England: Lippincott Williams & Wilkins.
29. Niittynen, L., M.L. Nurminen, R. Korpela, and H. Vapaatalo. 1999. Role of arginine, taurine and homocysteine in cardiovascular diseases. Annals of Internal Medicine 31: 318-26.
30. O'Connor, P.G., and T.R. Kosten. 1998. Rapid and ultrarapid opioid detoxification techniques. Journal of American Medical Association 279: 229-34.
31. Oja, S.S., and P. Saransaari. 2007. Pharmacology of taurine. Proceeding of the Western Pharmacology Society 50: 8-15.
32. O'Neal, C.L., and A. Poklis. 1998. The detection of acetylcodeine and 6-acetylmorphine in opiate positive urines. Forensic Science International 95: 1-10.
33. Patel, J., N. Manjappa, R. Bhat, P. Mehrotra, M. Bhaskaran, and P.C. Singhal. 2003. Role of oxidative stress and heme oxygenase activity in morphine-induced glomerular epithelial cell growth. American Journal of Physiology - Renal Physiology 285: F861-9.
34. Pereska, Z., B. Dejanova, C. Bozinovska, and L. Petkovska. 2007. Prooxidative/antioxidative homeostasis in heroin addiction and detoxification. Bratisl Lek Listy 108: 393-8.
35. Schildkraut, J.J., R.E. Meyer, P.J. Orsulak, S.M. Mirin, M. Roffman, P.A. Platz, E. Grab, M.E. Randall, and M. McDougle. 1977. Catecholamine metabolism during heroin use. American Journal of Psychiatry 134: 534-7.
36. Seidel, J.C., N. Nath, and A.E. Harper. 1960. Diet and cholesterolemia. V. Effects of sulfurcontaining amino acids and protein. Journal of Lipid Research 1: 474-81.
37. Shin, H.K., and H.M. Linkswiler. 1974. Tryptophan and methionine metabolism of adult females as affected by vitamin B-6 deficiency. Journal of Nutrition 104: 1348-55.
38. Spano, M.S., L. Fattore, W. Fratta, and P. Fadda. 2007. The GABAB receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. Neuropharmacology 52: 1555-62.
39. Timbrell, J.A., V. Seabra, and C.J. Waterfield. 1995. The in vivo and in vitro protective properties of taurine. General Pharmacology 26: 453-62.
40. Ward, R.J., M. Francaux, C. Cuisinier, X. Sturbois, and P. De Witte. 1999. Changes in plasma taurine levels after different endurance events. Amino Acids 16: 71-7.
41. Waterfield, C.J., J.A. Turton, M.D. Scales, and J.A. Timbrell. 1991. Taurine, a possible urinary marker of liver damage: A study of taurine excretion in carbon tetrachloride-treated rats. Archives of Toxicology 65: 548-55.
42. Wu, J., T. Kohno, S.K. Georgiev, M. Ikoma, H. Ishii, A.B. Petrenko, and H. Baba. 2008. Taurine activates glycine and gamma-aminobutyric acid A receptors in rat substantia gelatinosa neurons. Neuroreport 19: 333-7.
43. Xiang, Y., H. Gao, H. Zhu, N. Sun, Y. Ma, and H. Lei. 2006. Neurochemical changes in brain induced by chronic morphine treatment: NMR studies in thalamus and somatosensory cortex of rats. Neurochemical Research 31: 1255-61.